סטרנסיק 40 מ"ג/מ"ל - Strensiq 40 mg/ml

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×¡××¨× ×¡××§ 100 ×"×/×"× - Strensiq 100 mg/ml

×§×××¦× ×¤×¨××§××××××ª (ATC4)

A16AB
Enzymes

××¨××× ×¤×¢×× (ATC5)

Asfotase alfa 40MG / 1 ML âA16AB13

×¦××¨×ª ××ª×

×ª×ª-×¢××¨× - S.C

×¦××¨×ª ××× ××

×ª×××¡× ××××¨×§×, SOLUTION FOR INJECTION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Strensiq is indicated for long-term enzyme replacement therapy in patients with paediatric-onset hypophosphatasia to treat the bone manifestations of the disease.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

12/01/2017

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××ª×¨××¤× ×ª×× ×ª× ××××¤×× × pediatric-onset hypophosphatasia	12/01/2017	×××××ª ××××××××ª

××¡××¨×ª ××××× ××¡×

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.12.2023 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leaflet â31.12.2023 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.12.2023 ××¨×××¡ ×××××¤× ×¢××¨××ª 16.04.2018 ××××¨×ª ××××¢ ××××××ª× ×××××¤×/×××¨× ××××¤×/×××¤× ×¢××§×¨× ×× ××××ª 21.12.2022 ××××¨×ª ××××¢ ××××××ª× ×××××¤×/×××¨× ××××¤×/×××¤× ×¢××§×¨× ×¢××¨××ª 21.12.2022 ××××¨×ª ××××¢ ××××××ª× ×××××¤×/×××¨× ××××¤×/×××¤× ×¢××§×¨× ×× ××××ª 21.12.2022 ××××¨×ª ××××¢ ××××××ª× ×××××¤×/×××¨× ××××¤×/×××¤× ×¢××§×¨× ×¢××¨××ª 21.12.2022

×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¡××¨× ×¡××§ 40 ×"×/×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	ALEXION PHARMA GMBH, SWITZERLAND
×©× ××¢× ××¨××©××	ALEXION PHARMA ISRAEL LTD
×¨××©×××	×ª××¨×× ×××©×: 08/2015. ×¨××©××× ××ª××¨××: 02/2016
×ª××¨×× ×¢×××× ×××¨××	25/02/24

השינוי האחרון נעשה בֹ־25 בפברואר 2024 ב־07:14

סטרנסיק 40 מ"ג/מ"ל - Strensiq 40 mg/ml

ויקיתרופות